Public articles linked to the same research event.
World Journal of Methodology This review systematically evaluates the methodological quality, clinical validity, and translational evidence of cutting-edge technologies in the precision management of gastrointestinal tumor-associated osteoporosis (GTO), summarizing their current applications in AI-assisted early screening and risk prediction, nano-enabled targeted bone protection, and multiomics-based exploration of the tumor-bone-gut axis, and discussing barriers to clinical translation such as limited AI generalizability, nanomedicine safety and manufacturing challenges, difficulties in multidimensional data integration and standardization, imperfect multidisciplinary collaboration, and ethical concerns, concluding that these technologies are expected to move GTO management from empirical practice toward precision m
This review systematically evaluates the methodological quality, clinical validity, and translational evidence of cutting-edge technologies in the precision management of gastrointestinal tumor-associated osteoporosis (GTO), summarizing their current applications in AI-assisted early screening and risk prediction, nano-enabled targeted bone protection, and multiomics-based exploration of the tumor-bone-gut axis, and discussing barriers to clinical translation such as limited AI generalizability, nanomedicine safety and manufacturing challenges, difficulties in multidimensional data integration and standardization, imperfect multidisciplinary collaboration, and ethical concerns, concluding that these technologies are expected to move GTO management from empirical practice toward precision m
This review systematically evaluates the methodological quality, clinical validity, and translational evidence of cutting-edge technologies in the precision management of gastrointestinal tumor-associated osteoporosis (GTO), summarizing their current applications in AI-assisted early screening and risk prediction, nano-enabled targeted bone protection, and multiomics-based exploration of the tumor-bone-gut axis, and discussing barriers to clinical translation such as limited AI generalizability, nanomedicine safety and manufacturing challenges, difficulties in multidimensional data integration and standardization, imperfect multidisciplinary collaboration, and ethical concerns, concluding that these technologies are expected to move GTO management from empirical practice toward precision m
This review systematically evaluates the methodological quality, clinical validity, and translational evidence of cutting-edge technologies in the precision management of gastrointestinal tumor-associated osteoporosis (GTO), summarizing their current applications in AI-assisted early screening and risk prediction, nano-enabled targeted bone protection, and multiomics-based exploration of the tumor-bone-gut axis, and discussing barriers to clinical translation such as limited AI generalizability, nanomedicine safety and manufacturing challenges, difficulties in multidimensional data integration and standardization, imperfect multidisciplinary collaboration, and ethical concerns, concluding that these technologies are expected to move GTO management from empirical practice toward precision m